XML 96 R74.htm IDEA: XBRL DOCUMENT v2.4.0.8
17. Parent Company Financial Statements (Details 2) (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Adjustments to reconcile net loss to net cash provided/(used) in operating activities:    
Stock-based compensation $ 1,760,072 $ 686,059
Change in fair value of warrant liability (197,127) 97,022
Changes in assets and liabilities:    
Prepaid expenses 13,535 148,166
Net cash (used in) operating activities (1,683,125) (16,931,727)
Financing activities:    
Equity Offering 1,075,200  
Warrants exercised 1,082,735 1,433
Net cash used by financing activities 6,249,916 33,336,449
Net increase/(decrease) in cash and cash equivalents 4,635,217 41,137
Cash and cash equivalents at beginning of period 290,603 249,466
Cash and cash equivalents at end of period 4,925,820 290,603
Supplemental disclosures of cash flow information, cash paid:    
Income tax expense (5,765) 4,000
Supplemental disclosures of cash flow information, non-cash transactions:    
Issuance of warrants to subordinated debt holders 1,127,120 0
Issuance of shares for acquisition 0 12,511,200
Issuance of shares to related party for repayment of line of credit 821,946 4,107,141
Other asset transferred to related party 170,000 0
Warrant liability transferred to equity upon exercise 1,006,648 0
Parent Company Financial Statements
    
Operating activities:    
Net loss (24,437,209) (4,282,265)
Adjustments to reconcile net loss to net cash provided/(used) in operating activities:    
Stock-based compensation 1,760,072 686,059
Amortization of debt issuance discount 0 400,997
Change in fair value of warrant liability (197,127) 97,022
Changes in assets and liabilities:    
Subsidiary portion of net losses 22,134,091 12,496
Prepaid expenses 0 4,668
Accounts payable (639,843) 236,887
Accrued interest expense 0 682,983
Other liabilities (177,896) 288,203
Net cash (used in) operating activities (1,557,912) (1,872,950)
Investing activities:    
Change in outstanding checks in excess of cash (25,773) 25,773
Subsidiary advances, net 514,668 9,417,256
Net cash provided in investing activities 488,895 9,443,029
Financing activities:    
Proceeds from borrowings under secured debt facilities 0 840,000
Repayments of borrowings under secured debt facilities 0 (8,412,259)
Equity Offering 1,075,200 0
Warrants exercised 7,535 1,433
Net cash used by financing activities 1,082,735 (7,570,826)
Net increase/(decrease) in cash and cash equivalents 13,718 (747)
Cash and cash equivalents at beginning of period 0 747
Cash and cash equivalents at end of period 13,718 0
Supplemental disclosures of cash flow information, cash paid:    
Interest payments 4,522,097 2,084,751
Income tax expense 5,765 4,000
Supplemental disclosures of cash flow information, non-cash transactions:    
Issuance of warrants to non-employees to secure procurement and working capital 335,617 0
Issuance of warrants to subordinated debt holders 1,127,120 0
Issuance of shares for acquisition 0 12,511,200
Payments of principal, fees and interest by issuance of stock 3,616,284 11,885,579
Issuance of shares to related party for repayment of line of credit 821,946 4,107,141
Beneficial conversion discount on related party debt 0 884,851
Other asset transferred to related party 170,000 0
Warrant liability transferred to equity upon exercise $ 1,006,648 $ 0